Virtu Financial LLC Annovis Bio, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2022	SELL	$17.58 - $37.67 $202,996 - $434,975	-11,547 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$30.95 - $120.97 $182,450 - $713,118	-5,895 Reduced 33.8%	11,547 $367,000
Q2 2021 Sep 17, 2021	BUY	$21.55 - $96.1 $204,531 - $912,085	9,491 Added 119.37%	17,442 $1.49 Million
Q1 2021 May 19, 2021	BUY	$8.15 - $38.44 $64,800 - $305,636	7,951 New	7,951 $222,000

1.16M

229K

934K

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $55.4M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.